Newswire23d
CordenPharma and Viking Therapeutics Sign Long-Term Strategic Partnership for Integrated Supply of GLP-1 Peptides, Injectables and Oral Formulations
CordenPharma and Viking Therapeutics sign multi-year strategic partnership to support the commercial demand of Viking Therapeutics' GLP-1 drug candidate VK2735. CordenPharma provides large-scale ...
PR Newswire29d
CordenPharma Expands Peptide Platform with more than 500 Million Euro Greenfield Facility Construction in the Basel Region of Switzerland
The expansion will more than double the existing SPPS reactor capacity at CordenPharma Colorado by adding an additional 25,000 L of SPPS capacity – making it a total reactor capacity of >42,000 ...
The Victoria Advocate29d
CordenPharma amplía su plataforma de péptidos con la construcción de una nueva instalación en Basilea (Suiza)
- CordenPharma amplía su plataforma de péptidos con la construcción de una nueva instalación por valor de más de 500 millones de euros en la región de Basilea (Suiza) ...
FiercePharma23d
Viking pays $150M to recruit CordenPharma for obesity drug manufacturing saga
Less than a year after CordenPharma earmarked a major chunk of change to beef up in peptide manufacturing for GLP-1s and other drugs, the CDMO’s investment plan is paying off big time.
Yahoo Finance23d
CordenPharma and Viking Therapeutics Sign Long-Term Strategic Partnership for Integrated Supply of GLP-1 Peptides, Injectables and Oral Formulations
CordenPharma and Viking Therapeutics sign multi-year strategic partnership to support the commercial demand of Viking Therapeutics' GLP-1 drug candidate VK2735. CordenPharma provides large-scale ...
FiercePharma29d
CordenPharma to build €500M Swiss peptide plant, generating 300 new jobs
After earmarking a major chunk of change last year to bulk up in peptide production, European CDMO CordenPharma is putting its money where its mouth is. CordenPharma will spend half of a planned ...
Morningstar29d
CordenPharma Expands Peptide Platform with more than 500 Million Euro Greenfield Facility Construction in the Basel Region of Switzerland
BASEL, Switzerland, March 5, 2025 /PRNewswire/ -- Following its 16 July 2024 announcement, CordenPharma is pleased to share significant progress on its growth initiatives with a >€1 billion ...